The Latest Breaking News on Pharma

The need for more advanced biotech research and development has increased amid an aging population and growing medical needs. Investors' sentiment toward biotech stocks has improved significantly over the past months. Given the industry's solid prospects, fundamentally sound biotech stocks Exelixis (EXEL), Innoviva (INVA), and Cidara Therapeutics (CDTX) might be…

Berlin has sent its first batch of BioNTech COVID-19 vaccines to China to be administered initially to German expatriates, a German government spokesperson said on Wednesday, the first foreign coronavirus vaccine to be delivered to the country.

DEA says it seized more than 379 million potentially lethal doses of fentanyl in 2022

MPs have been told the release of documents on coronavirus contracts awarded to PPE Medpro might have to wait for criminal investigations to end.

Walgreens will limit online orders of children's fever and pain medicine to six items "to help support availability and avoid excess purchases." At CVS stores, purchases will be limited to two.

The biotechnology firm has been bought by Molecular Devices for an undisclosed sum

The German government said Tuesday that it will allow health insurance companies to pay more for pediatric medications that are in short supply in the country

Gilead Sciences (GILD) beat revenue and earnings estimates in the previous quarter and upgraded its guidance for fiscal 2022. Having risen more than 19% year-to-date, is GILD still a buy? Read on to learn our view.

A parliamentary committee in Gambia said on Tuesday that India-based drug maker Maiden Pharmaceuticals Ltd was responsible for the deaths of at least 70 children from acute kidney injury and called on the government to pursue legal action.